Machine Learning

Debuting at MIP London, Bunqer.tech uses AI to create an 'online shopping' experience for TV rights, unlocking value in vast back catalogs.

With triple-digit growth, the firm's partner-led model is dominating the market as companies race to defend against escalating third-party cyber threats.

QuickLogic will showcase an eFPGA chiplet on Intel's 18A process at Chiplet Summit 2026, signaling a new era of flexible, post-silicon hardware design.

Behind the roar of the crowd, Atos's tech backbone kept UEFA's biggest events running perfectly. Here's how they're shaping the future of global sports.

UCLA's Dr. Donald Kohn joins the Jeffrey Modell Foundation to discuss revolutionary gene therapies offering new hope for Primary Immunodeficiency patients.

With non-human identities exploding, GitGuardian's Series C, led by Insight Partners, tackles the urgent security gap for AI agents and automated systems.

A new AI-powered solution from Emburse promises to transform expense management by catching errors and fraud before reports are even submitted.

At a key summit, Candel Therapeutics will showcase how its oncolytic virus, CAN-3110, uses biomarkers to fight one of the deadliest brain cancers.

Rapid7's 2026 awards reveal a shift in cybersecurity, where partners are no longer just resellers but crucial allies in the global, AI-driven fight.

A new collaboration with Datavant will securely connect real-world health data, aiming to speed up research and deliver life-saving therapies faster.

HeartCore Enterprises forecasts a dramatic swing to profitability in 2025 after divesting its software unit, betting its future on IPO consulting.

Global tech firm Mastek deepens its UK roots with a new Leeds AI hub, boosting the region's economy and tackling the digital skills gap.

Lantern's expanded cancer solution uses NCI-level expertise and community care to promise better outcomes and a significant return on investment for employers.

BenQ's new InstaShow VS25 challenges the status quo with a hardware-only system, promising app-free, secure meetings for the modern hybrid workplace.

Financially robust and debt-free, Rail Vision is rapidly expanding its AI safety systems globally while a new quantum computing arm aims to redefine the future of rail.

The online reputation firm Ealixir is moving beyond content removal, launching an editorial service to build AI-proof digital identities through authorship.

SOFIE Biosciences' FAPI-PRO trial begins, testing a novel radiotracer that could revolutionize the detection of one of the deadliest forms of cancer.

Daré Bioscience launches telehealth for DARE to PLAY™, the first evidence-backed topical sildenafil cream designed to address female sexual arousal.

New 3D human tissue models show groundbreaking promise in predicting toxicity for advanced cancer therapies, heralding a major shift away from animal testing.

LiveOne is set to announce three new Fortune 500 partnerships alongside better-than-expected Q3 results, signaling a major push into the enterprise market.